Sboner, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 1.369
EU - Europa 222
AS - Asia 198
OC - Oceania 2
Totale 1.791
Nazione #
US - Stati Uniti d'America 1.364
SG - Singapore 82
IT - Italia 56
CN - Cina 54
SE - Svezia 36
VN - Vietnam 28
DE - Germania 26
GB - Regno Unito 22
FI - Finlandia 20
UA - Ucraina 15
BG - Bulgaria 14
ID - Indonesia 13
RU - Federazione Russa 10
HK - Hong Kong 6
IN - India 6
JO - Giordania 6
CA - Canada 5
LU - Lussemburgo 5
PL - Polonia 4
CZ - Repubblica Ceca 3
NO - Norvegia 3
AT - Austria 2
NL - Olanda 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
ES - Italia 1
GR - Grecia 1
JP - Giappone 1
LK - Sri Lanka 1
LT - Lituania 1
RS - Serbia 1
Totale 1.791
Città #
Fairfield 230
Chandler 154
Ashburn 135
Woodbridge 111
Cambridge 80
Seattle 80
Houston 72
Wilmington 72
Singapore 69
Ann Arbor 56
Santa Clara 41
San Mateo 40
Princeton 33
Columbus 31
Jacksonville 29
San Diego 23
Beijing 21
Dong Ket 20
Bremen 17
Trento 16
Helsinki 15
Sofia 14
Jakarta 13
Como 11
Dearborn 10
Boardman 7
London 7
Moscow 7
San Paolo di Civitate 7
Hong Kong 6
New York 6
Tolentino 6
Falls Church 5
Hesperange 5
Kilburn 4
Los Angeles 4
Nanjing 4
Phoenix 4
Altamura 3
Bend 3
Brno 3
Chiswick 3
Civitanova Marche 3
Hefei 3
Norwalk 3
Oslo 3
Shanghai 3
Toronto 3
Andover 2
Auckland 2
Bolzano 2
Castello Molina di Fiemme 2
Clearwater 2
Dallas 2
Des Moines 2
Laurel 2
Ottawa 2
Pune 2
Amsterdam 1
Anaheim 1
Belgrade 1
Bonndorf 1
Chicago 1
Chieti 1
Chongqing 1
Colombo 1
Fayetteville 1
Frankfurt am Main 1
Fremont 1
Guangzhou 1
Huaihua 1
Lawrence 1
Madrid 1
Manassas 1
Mountain View 1
Nanyang 1
Newark 1
Philadelphia 1
Raleigh 1
Richmond 1
Riva 1
St Petersburg 1
Vienna 1
Warsaw 1
Washington 1
Weihai 1
Xingtai 1
Zgierz 1
Zhengzhou 1
Totale 1.546
Nome #
Inherited determinants of early recurrent somatic mutations in prostate cancer 252
ASEQ: Fast allele-specific studies from next-generation sequencing data 160
Patient derived organoids to model rare prostate cancer phenotypes 154
Personalized in vitro and in vivo cancer models to guide precision medicine 151
Genomic correlates of clinical outcome in advanced prostate cancer 141
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 121
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. 120
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 120
A multiple classifier system for early melanoma diagnosis 111
ABEMUS: platform specific and data informed detection of somatic SNVs in cfDNA 82
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes 68
Clinical validation of an automated system for supporting the early diagnosi of melanoma 65
Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models 65
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer 60
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity 57
The long tail of oncogenic drivers in prostate cancer 53
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer 41
Simple methods for peak and valley detection in time series microarray data 27
Totale 1.848
Categoria #
all - tutte 8.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 0 0 0 0 0 0 37 25 45 60 21 17
2020/2021449 6 74 35 37 21 44 41 20 26 34 45 66
2021/2022316 64 19 1 16 3 24 3 65 14 35 32 40
2022/2023327 39 53 2 61 28 49 4 18 44 0 11 18
2023/2024109 5 10 9 5 14 26 8 12 0 7 2 11
2024/2025213 3 2 33 88 34 53 0 0 0 0 0 0
Totale 1.848